Table 13.
Reference | Type of study | Test system | Dose |
---|---|---|---|
Study No. 997‐471‐5889 (Vértesi, 2021) | Bacterial reverse mutation test (GLP, OECD TG 471) | S. Typhimurium TA98, TA100, TA1535 and TA1537 and E. coli WP2 uvrA | Up to 5,000 μg/plate (absence and presence of S9 mix) |
Study No. 997‐487‐5890 (Fekete, 2021) | In vitro mammalian cell micronucleus test (GLP, OECD TG 487) | L5178Y tk+/ 3.7.2c (IVGT) mouse lymphoma cell line | Up to 400 ug/mL (absence of S9 mix) and up to 600 ug/mL (presence of S9 mix) |
bw: body weight; GLP: Good Laboratory Practice; OECD TG: Organisation for Economic Co‐operation and Development Test Guideline.